Woodline Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.1M | Sell |
4,000,033
-1,253,323
| -24% | -$14.1M | 0.24% | 117 |
|
|
2025
Q1 | $53M | Sell |
5,253,356
-878,592
| -14% | -$8.86M | 0.34% | 77 |
|
|
2024
Q4 | $72.5M | Sell |
6,131,948
-2,554,528
| -29% | -$30.2M | 0.49% | 38 |
|
|
2024
Q3 | $100M | Buy |
8,686,476
+685,537
| +9% | +$7.91M | 0.84% | 19 |
|
|
2024
Q2 | $84.6M | Sell |
8,000,939
-3,171,367
| -28% | -$33.5M | 0.81% | 22 |
|
|
2024
Q1 | $118M | Buy |
11,172,306
+5,020,539
| +82% | +$52.9M | 1.08% | 11 |
|
|
2023
Q4 | $69.1M | Sell |
6,151,767
-1,022,486
| -14% | -$11.5M | 0.75% | 29 |
|
|
2023
Q3 | $83.8M | Buy |
7,174,253
+3,377,382
| +89% | +$39.4M | 0.98% | 19 |
|
|
2023
Q2 | $38.3M | Buy |
3,796,871
+236,320
| +7% | +$2.38M | 0.45% | 55 |
|
|
2023
Q1 | $26.3M | Sell |
3,560,551
-1,145,434
| -24% | -$8.45M | 0.36% | 84 |
|
|
2022
Q4 | $37.6M | Buy |
4,705,985
+2,206,650
| +88% | +$17.6M | 0.5% | 39 |
|
|
2022
Q3 | $8.05M | Buy |
+2,499,335
| New | +$8.05M | 0.11% | 223 |
|